Last reviewed · How we verify
NCT04002466: AnemEE
Anemia Etiology Evaluation in Ethiopia
trial testing Risk factors for anemia in Anemia in 5,114 participants. Completed in 15 August 2019.
15 August 2019
Quick facts
| Lead sponsor | Harvard School of Public Health (HSPH) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 5,114 |
| Start date | 27 January 2019 |
| Primary completion | 15 August 2019 |
| Estimated completion | 15 August 2019 |
| Sites | 1 location across Ethiopia |
Drugs / interventions tested
- Risk factors for anemia
Conditions studied
- Anemia — all drugs for Anemia →
Sponsor
Harvard School of Public Health (HSPH)
Who can join
Adults 6 Months to 48, any sex, with Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The AnemEE study is a population-based anemia etiology survey in six regions of Ethiopia. The primary aim of the study is to evaluate the relative contribution of risk factors for anemia among children, women of reproductive age, and adult men. The study data are intended to inform evidence-based decision-making on anemia control interventions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Anemia prevalence and etiology among women, men, and children in Ethiopia: a study protocol for a national population-based survey.
Tadesse AW, Hemler EC, Andersen C, Passarelli S, et al · · 2019 · cited 17× · PMID 31651278 · DOI 10.1186/s12889-019-7647-7
Verify or expand the search:
- PubMed search for NCT04002466
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anemia
Currently open trials in the same condition.
- NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
- NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
- NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
- NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
- NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting
Other Harvard School of Public Health (HSPH) trials
Trials by the same sponsor.
- NCT07493772 — Multiple Micronutrient Supplementation With Digital Layering Among Adolescents in Tanzania · NA · not yet recruiting
- NCT06982339 — Beat the Heat Boston · NA · recruiting
- NCT06765863 — LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk · NA · recruiting
- NCT06102044 — Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania · Phase 3 · recruiting
- NCT06390943 — Low Birthweight and Preterm Infant Feeding Trial and Supportive Care Package: Implementation Research · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04002466 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Harvard School of Public Health (HSPH)
- Last refreshed: 28 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04002466.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing